Cargando…
Antibody-mediated targeting of iron oxide nanoparticles to the folate receptor alpha increases tumor cell association in vitro and in vivo
Active molecular targeting has become an important aspect of nanoparticle development for oncology indications. Here, we describe molecular targeting of iron oxide nanoparticles (IONPs) to the folate receptor alpha (FOLRα) using an engineered antibody fragment (Ffab). Compared to control nanoparticl...
Autores principales: | Ndong, Christian, Toraya-Brown, Seiko, Kekalo, Katsiaryna, Baker, Ian, Gerngross, Tillman U, Fiering, Steven N, Griswold, Karl E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388088/ https://www.ncbi.nlm.nih.gov/pubmed/25878495 http://dx.doi.org/10.2147/IJN.S79367 |
Ejemplares similares
-
Tumor Cell Targeting by Iron Oxide Nanoparticles Is Dominated by Different Factors In Vitro versus In Vivo
por: NDong, Christian, et al.
Publicado: (2015) -
Local tumour hyperthermia as immunotherapy for metastatic cancer
por: Toraya-Brown, Seiko, et al.
Publicado: (2014) -
Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles
por: Gui, Gang, et al.
Publicado: (2021) -
Brain Uptake of Folate Forms in the Presence of Folate Receptor Alpha Antibodies in Young Rats: Folate and Antibody Distribution
por: Bobrowski-Khoury, Natasha, et al.
Publicado: (2023) -
Connecting the sequence dots: shedding light on the genesis of antibodies reported to be designed in silico
por: Vásquez, Maximiliano, et al.
Publicado: (2019)